- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/49 - Urokinase; Tissue plasminogen activator
Patent holdings for IPC class A61K 38/49
Total number of patents in this class: 251
10-year publication summary
|
17
|
8
|
20
|
26
|
29
|
29
|
14
|
12
|
15
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Talengen International Limited | 87 |
13 |
| Thornhill Therapeutics, Inc. | 26 |
9 |
| Board of Regents, The University of Texas System | 5619 |
6 |
| PAION Deutschland GmbH | 19 |
6 |
| Vertex Pharmaceuticals Incorporated | 1568 |
5 |
| Children's Medical Center Corporation | 1826 |
5 |
| National Jewish Health | 163 |
5 |
| NoNO Inc. | 86 |
5 |
| The Research Foundation for The State University of New York | 1552 |
5 |
| Shimojani, LLC | 7 |
5 |
| Thrombolytic Science, LLC | 7 |
5 |
| Annexin Pharmaceuticals AB | 21 |
4 |
| Case Western Reserve University | 1770 |
4 |
| Genentech, Inc. | 3869 |
3 |
| The Regents of the University of Michigan | 4578 |
3 |
| Hadasit Medical Research Services & Development Limited | 142 |
3 |
| Icahn School of Medicine at Mount Sinai | 905 |
3 |
| Indiana University Research and Technology Corporation | 800 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
3 |
| NC Medical Research Inc. | 4 |
3 |
| Other owners | 153 |